Literature DB >> 21051663

Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation.

Jie Chen1, Hao Yin, Yulan Jiang, Sarvan Kumar Radhakrishnan, Zhan-Peng Huang, Jingjing Li, Zhan Shi, Elisabeth P C Kilsdonk, Yu Gui, Da-Zhi Wang, Xi-Long Zheng.   

Abstract

OBJECTIVE: Myocardin is a cardiac- and smooth muscle-specific transcription co-factor that potently activates the expression of downstream target genes. Previously, we demonstrated that overexpression of myocardin inhibited the proliferation of smooth muscle cells (SMCs). Recently, myocardin was reported to induce the expression of microRNA-1 (miR-1) in cardiomyocytes. In this study, we investigated whether myocardin induces miR-1 expression to mediate its inhibitory effects on SMC proliferation. METHODS AND
RESULTS: Using tetracycline-regulated expression (T-REx) inducible system expressing myocardin in human vascular SMCs, we found that overexpression of myocardin resulted in significant induction of miR-1 expression and inhibition of SMC proliferation, which was reversed by miR-1 inhibitors. Consistently, introduction of miR-1 into SMCs inhibited their proliferation. We isolated spindle-shaped and epithelioid human SMCs and demonstrated that spindle-shaped SMCs were more differentiated and less proliferative. Correspondingly, spindle-shaped SMCs had significantly higher expression levels of both myocardin and miR-1 than epithelioid SMCs. We identified Pim-1, a serine/threonine kinase, as a target gene for miR-1 in SMCs. Western blot and luciferase reporter assays further confirmed that miR-1 targeted Pim-1 directly. Furthermore, neointimal lesions of mouse carotid arteries displayed downregulation of myocardin and miR-1 with upregulation of Pim-1.
CONCLUSIONS: Our data demonstrate that miR-1 participates in myocardin-dependent of SMC proliferation inhibition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051663      PMCID: PMC3207238          DOI: 10.1161/ATVBAHA.110.218149

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  35 in total

1.  RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS.

Authors:  Takuya Mishima; Yoshiaki Mizuguchi; Yutaka Kawahigashi; Takami Takizawa; Toshihiro Takizawa
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

2.  MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy.

Authors:  John J McCarthy; Karyn A Esser
Journal:  J Appl Physiol (1985)       Date:  2006-09-28

3.  Isolation of two morphologically distinct cell lines from rat arterial smooth muscle expressing high tumorigenic potentials.

Authors:  N Blaes; M C Bourdillon; J M Daniel-Lamaziere; J J Michaille; M Andujar; C Covacho
Journal:  In Vitro Cell Dev Biol       Date:  1991-09

4.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.

Authors:  Yong Zhao; Eva Samal; Deepak Srivastava
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

5.  Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow.

Authors:  A Kumar; V Lindner
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

6.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation.

Authors:  Jian-Fu Chen; Elizabeth M Mandel; J Michael Thomson; Qiulian Wu; Thomas E Callis; Scott M Hammond; Frank L Conlon; Da-Zhi Wang
Journal:  Nat Genet       Date:  2005-12-25       Impact factor: 38.330

7.  Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment.

Authors:  X-L Zheng; S-G Yuan; D-Q Peng
Journal:  Diabetologia       Date:  2007-02-14       Impact factor: 10.122

8.  Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect.

Authors:  Michael Milyavsky; Igor Shats; Alina Cholostoy; Ran Brosh; Yosef Buganim; Lilach Weisz; Ira Kogan; Merav Cohen; Maria Shatz; Shalom Madar; Eyal Kalo; Naomi Goldfinger; Jun Yuan; Shulamit Ron; Karen MacKenzie; Amir Eden; Varda Rotter
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

9.  MicroRNAs play an essential role in the development of cardiac hypertrophy.

Authors:  Danish Sayed; Chull Hong; Ieng-Yi Chen; Jacqueline Lypowy; Maha Abdellatif
Journal:  Circ Res       Date:  2007-01-18       Impact factor: 17.367

10.  Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.

Authors:  Yong Zhao; Joshua F Ransom; Ankang Li; Vasanth Vedantham; Morgan von Drehle; Alecia N Muth; Takatoshi Tsuchihashi; Michael T McManus; Robert J Schwartz; Deepak Srivastava
Journal:  Cell       Date:  2007-03-29       Impact factor: 41.582

View more
  55 in total

Review 1.  MicroRNA regulation of smooth muscle gene expression and phenotype.

Authors:  Hara Kang; Akiko Hata
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

Review 2.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

Review 3.  microRNAs in cardiovascular development.

Authors:  Jinghai Chen; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2012-01-24       Impact factor: 5.000

Review 4.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Authors:  Ming-Jie Zhang; Yi Zhou; Lei Chen; Yan-Qin Wang; Xu Wang; Yan Pi; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

Review 5.  MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling.

Authors:  Robert A McDonald; Akiko Hata; Margaret R MacLean; Nicholas W Morrell; Andrew H Baker
Journal:  Cardiovasc Res       Date:  2011-11-07       Impact factor: 10.787

Review 6.  Regulation of cardiac myocyte cell death and differentiation by myocardin.

Authors:  Joseph W Gordon
Journal:  Mol Cell Biochem       Date:  2017-06-19       Impact factor: 3.396

Review 7.  Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation.

Authors:  Brandi N Davis-Dusenbery; Connie Wu; Akiko Hata
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 8.  Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease.

Authors:  Nicholas J Leeper; Lars Maegdefessel
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

9.  Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension.

Authors:  J E Kontaraki; M E Marketou; E A Zacharis; F I Parthenakis; P E Vardas
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

10.  Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation.

Authors:  Yulan Jiang; Pavneet Singh; Hao Yin; Yi-Xia Zhou; Yu Gui; Da-Zhi Wang; Xi-Long Zheng
Journal:  J Cell Physiol       Date:  2013-10       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.